- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 31/603 - Acide salicyliqueSes dérivés ayant d'autres cycles aromatiques, p. ex. diflunisal
Détention brevets de la classe A61K 31/603
Brevets de cette classe: 57
Historique des publications depuis 10 ans
|
6
|
3
|
8
|
6
|
9
|
6
|
2
|
2
|
7
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| SOM Innovation Biotech, S.L. | 13 |
5 |
| Biosuccess Biotech Co. Ltd. | 25 |
4 |
| Sen-jam Pharmaceutical LLC | 13 |
3 |
| The Regents of the University of California | 19612 |
2 |
| Kao Corporation | 4913 |
2 |
| Alnylam Pharmaceuticals, Inc. | 1138 |
2 |
| Aurin Biotech Inc. | 11 |
2 |
| Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | 804 |
2 |
| University of Fukui | 79 |
2 |
| Vestlandets Innovasjonsselskap AS | 42 |
2 |
| Pfizer Inc. | 3318 |
1 |
| Purdue Research Foundation | 3504 |
1 |
| Allergan Pharmaceuticals International Limited | 216 |
1 |
| Alma Mater Studiorum - Universita di Bologna | 393 |
1 |
| Antibe Therapeutics Inc. | 19 |
1 |
| Board of Supervisors of Louisiana State University | 31 |
1 |
| Boyce Thompson Institute for Plant Research, Inc. | 31 |
1 |
| Brown University | 632 |
1 |
| China Pharmaceutical University | 278 |
1 |
| Chu de Bordeaux | 20 |
1 |
| Autres propriétaires | 21 |